A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons

Therapeutic use of general sodium channel blockers, such as lidocaine, can substantially reduce the enhanced activity in sensory neurons that accompanies chronic pain after nerve or tissue injury. However, because these general blockers have significant side effects, there is great interest in developing inhibitors that specifically target subtypes of sodium channels. Moreover, some idiopathic small-fiber neuropathies are driven by gain-of-function mutations in specific sodium channel subtypes. In the current study, we focus on one subtype, the voltage-gated sodium channel 1.8 (Na(v)1.8). Na(v)1.8 is preferentially expressed in nociceptors, and gain-of-function mutations in Na(v)1.8 result in painful mechanical hypersensitivity in humans. Here, we used the recently developed gain-of-function Na(v)1.8 transgenic mouse strain, Possum, to investigate Na(v)1.8-mediated peripheral afferent hyperexcitability. This gainof- function mutation resulted in markedly increased mechanically evoked action potential firing in subclasses of Ab, Ad, and C fibers. Moreover, mechanical stimuli initiated bursts of action potential firing in specific subpopulations that continued for minutes after removal of the force and were not susceptible to conduction failure. Surprisingly, despite the intense afferent firing, the behavioral effects of the Na(v)1.8 mutation were quite modest, as only frankly noxious stimuli elicited enhanced pain behavior. These data demonstrate that a Na(v)1.8 gain-of-function point mutation contributes to intense hyperexcitability along the afferent axon within distinct sensory neuron subtypes. (c) 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.